reported their experience of 16 patients with prolonged thrombocytopenia after alloHCT treated with 4-6 weekly administrations of umbilical cord MSC (1×106 cells/kg) in combination with avatrombopag (a second generation TPO-RA) (32). The gene discussed is TPO; the disease is Thrombocytopenia.